PIVOT-10: A phase II study of bempegaldesleukin (NKTR-214) in combination with nivolumab (NIVO) in cisplatin (cis) ineligible patients with previously untreated locally advanced or metastatic urothelial cancer (mUC)

Huddart R. A., Siefker-Radtke A. O., Balar A. V., Bilen M. A., Powles T., Bamias A., ...More

Genitourinary Cancers Symposium of the American-Society-of-Clinical-Oncology (ASCO), San-Francisco, Costa Rica, 13 - 15 February 2020, vol.38 identifier

  • Publication Type: Conference Paper / Summary Text
  • Volume: 38
  • City: San-Francisco
  • Country: Costa Rica
  • Istanbul University Affiliated: Yes